Black Friday

All the Features.
Half the Price.

$149.00 / first year $299.50

Then $299.50/year

Last Close
4.83
Nov 16 • 3:59 PM ET Dollar change-0.07 Percentage change(-1.43%)
Aftermarket Close
4.83
Aftermarket • 7:30 PM ET Dollar change0.00 Percentage change(0.00%)
Index
RUT
Market Cap
546.30M
Enterprise Value
1.36B
Income
-507.69M
Sales
2.34B
Book/sh
3.30
Cash/sh
1.37
Dividend Est.
-
Dividend TTM
-
Dividend Ex-Date
-
Dividend Gr. 3/5Y
- -
Payout
-
Employees
4200
IPO
Jun 05, 2015
P/E
-
Forward P/E
12.97
PEG
0.18
P/S
0.23
P/B
1.47
P/C
3.53
P/FCF
14.90
EV/EBITDA
16.83
EV/Sales
0.58
Quick Ratio
1.26
Current Ratio
1.26
Debt/Eq
2.61
LT Debt/Eq
2.61
Option/Short
Yes / Yes
EPS (ttm)
-4.54
EPS next Y
0.37
EPS next Q
0.16
EPS this Y
150.32%
EPS next Y
65.35%
EPS next 5Y
73.79%
EPS past 3/5Y
-194.21% -5.21%
Sales past 3/5Y
11.54% 15.20%
EPS Y/Y TTM
-189.46%
Sales Y/Y TTM
14.06%
EPS Q/Q
11.73%
Sales Q/Q
51.27%
Insider Own
9.42%
Insider Trans
-0.61%
Inst Own
90.23%
Inst Trans
-2.62%
ROA
-23.00%
ROE
-83.57%
ROIC
-37.76%
Gross Margin
10.25%
Oper. Margin
-1.30%
Profit Margin
-21.67%
SMA20
3.99%
SMA50
14.24%
SMA200
22.98%
Trades
Shs Outstand
113.10M
Shs Float
102.45M
52W High
6.26 -22.78%
52W Low
2.10 130.55%
Volatility
6.07% 7.14%
ATR (14)
0.32
RSI (14)
56.94
Beta
1.00
Rel Volume
0.58
Avg Volume
2.17M
Volume
1,261,027
Perf Week
2.55%
Perf Month
5.69%
Perf Quarter
5.46%
Perf Half Y
23.85%
Perf YTD
20.75%
Perf Year
15.55%
Perf 3Y
-83.60%
Perf 5Y
-82.68%
Perf 10Y
-72.71%
Prev Close
4.90
Price
4.83
Change %
-1.43%
Consensus
Strong Buy
Avg. Price Target
$6.00
Implied Upside
+24.2%
Analysts13incl. previous ratings
Rating Distribution11 Buy · 2 Hold · 0 Sell
DateActionAnalystRating ChangePrice Target ChangeImplied Upside
Aug 11, 2026Upgrade
C logoCCitigroup
Neutral → Buy$6+24.2%
Jul 23, 2026Downgrade
C logoCCitigroup
Buy → Sell$6.75+39.8%
Jun 30, 2026Downgrade
TFC logoTTruist
Buy → Hold$7+44.9%
Feb 25, 2026Downgrade
KEY logoKKeyBanc Capital Markets
Overweight → Sector Weight
Nov 13, 2025Upgrade
SStephens
Equal-Weight → Overweight$7+44.9%
Nov 13, 2025Initiated
BMO logoBBMO Capital Markets
Outperform$7+44.9%
Jan 10, 2025Initiated
NNeedham
Buy$15+210.6%
Dec 03, 2024Reiterated
BBTIG Research
Buy$36 → $29+500.4%
Nov 08, 2024Downgrade
SStephens
Overweight → Equal-Weight$38 → $16+231.3%
Oct 11, 2024Initiated
KEY logoKKeyBanc Capital Markets
Overweight$35+624.6%
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
McCarthy Daniel JosephPRESIDENTAug 26 '26Sale5.0065,892329,460655,133Aug 28 04:17 PM
Daniel McCarthyOfficerAug 26 '26Proposed Sale4.9765,892327,476Aug 26 05:42 PM
Springstubb Brendan BDirectorNov 18 '25Buy3.8210,00038,19958,821Nov 19 04:23 PM
Evolent Health, Inc. engages in the provision of healthcare delivery and payment services. It deals with population health management, health plan and third party administration, network performance and pharmacy benefit management, risk adjustment, analytics and performance improvement, and technology and electronic medical record integration. The company was founded by Frank J. Williams, Seth B. Blackley, and Thomas Peterson III in August 2011 and is headquartered in Arlington, VA.
Co-FounderMr. Seth Barrie Blackley
PresidentMr. Dan McCarthy
Chief Legal OfficerMr. Jonathan David Weinberg J.D.
Chief Strategy OfficerMr. John Paul Johnson
Chief Financial OfficerMr. Mario Marques Ramos